Answers are grounded in this paper and cite their sources.
Study evaluates the role of basophil histamine content as a biomarker in chronic spontaneous urticaria and its predictive value for omalizumab response, suggesting limited utility.
Summary Our study confirms an association between basophil histamine content and features of type IIb CSU. However, this biomarker is not suitable for predicting omalizumab treatment response or treatment course.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: